Biotechnology News

November 20, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the Piper Jaffray 24th Annual Healthcare Conference on Tuesday, November 27, at 8:00 a.m. Eastern Standard Time. The...

November 20, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Affymax, Inc. (Nasdaq: AFFY) today announced the company’s participation in the following investors conferences. 24th Annual Piper Jaffray Health Care ConferenceTuesday, November 27, 2012 in New York City10:00...

November 20, 2012

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets...

November 20, 2012

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) announced today that the European Commission has approved ELIQUIS® (apixaban) for prevention of stroke and systemic embolism in adult...

November 20, 2012

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides reports filing of quarterly report and having sufficient cash in hand to advance its drug development programs.

November 20, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Health outcomes liaisons (HOLs) spend nearly an hour per visit with their clients, according to a report released by Cutting Edge Information.

November 20, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): For the third quarter July - September Net sales for the quarter amounted to SEK 26.7 million (26.3), corresponding to a 1.5 percent increase compared to the same period last...

November 20, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany TechnoGene Ltd. (ProSpec). In the beginning of 2013,...

November 20, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that researchers at...

November 20, 2012

TWINSBURG, Ohio--(BUSINESS WIRE)--A patent has been awarded to L.J. Star for its TCI ClampConnect™, a sanitary fitting that makes sterile/clean in place processes more sanitary by eliminating the dead leg of ordinary ferrule fittings that can...

November 20, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics is teaming up with PPD to resume its Phase IIb clinical trials using Oxycyte for traumatic brain injury. TBI is known as the signature wound of war.

November 20, 2012

HENNIGSDORF, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. today announced it has signed a long-term license agreement with Fujirebio Inc. to make its biomarker assay Procalcitonin (PCT) available in Japan.

November 20, 2012

SAN DIEGO--(BUSINESS WIRE)--MNTR signs $6 million Letter of Intent with nanotechnology cancer leader Nanovega, Inc. Nano-sized particles tag cancer cells and slip into solid tumors instead of bunching up on the cancer surface.

November 20, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that Edward J. Quilty, the Company’s chief executive officer, will present at the...

November 20, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix and CPGR in South Africa collaborate to enable genomics research for scientists across Africa to discover genetic markers specific in the African population for personalized medicine.

November 20, 2012

NESS ZIONA, Israel--(BUSINESS WIRE)--Atox Bio today reported positive top-line results from the AB103 randomized, double-blind, placebo-controlled Phase 2a trial in patients with Necrotizing Soft Tissue Infections (NSTI), a life-threatening...

November 20, 2012

LONDON--(BUSINESS WIRE)--New market research report “Innovative Hematology and Flow Cytometry Technologies and Emerging Markets” created by Venture Planning Group has been recently published at MarketPublishers.com

November 20, 2012

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Jane Wasman, President, International and General Counsel will present at the Piper Jaffray 24th Annual Healthcare Conference on Wednesday, November 28...

November 20, 2012

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN, ADR: IPSEY) (Paris:IPN) and Inspiration Biopharmaceuticals Inc. (Inspiration) today announced that Inspiration has received Fast Track designation from the US...

November 19, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cordis today announced the presentation of the INCRAFT™ AAA Stent-Graft System INNOVATION study one-year results at the 2012 Veith Symposium in New York City.

November 19, 2012

NORTH LIBERTY, Iowa--(BUSINESS WIRE)--KemPharm, Inc. receives positive feedback from FDA on KP201 Clinical Plan

November 19, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) received verbal notice from NYSE MKT LLC of the exchange’s decision to delist the Company’s common stock from the NYSE MKT, effective...

November 19, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced that Mark Goldberg, M.D., Senior Vice President...

November 19, 2012

DURHAM, N.C.--(BUSINESS WIRE)--Dr. Seth Rudnick has joined the Board of Directors of both Square 1 Financial, Inc. and Square 1 Bank. He has an extensive background in the venture capital industry, 30+ years in pharma and biotech

November 19, 2012

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium...

November 19, 2012

ATLANTA & NEW YORK & DENVER--(BUSINESS WIRE)--The National Down Syndrome Congress, the National Down Syndrome Society and the Global Down Syndrome Foundation announced a collaborative effort to address prenatal testing issues.

November 19, 2012

MUNICH--(BUSINESS WIRE)--The Image-Com 5.0 software is the newest addition to TomTec’s Image-Arena image management solution.

November 19, 2012

LAGUNA BEACH, Calif.--(BUSINESS WIRE)--3V07 Healthcare Advertising Add Ian Koff as New Creative Director

November 19, 2012

NEW YORK--(BUSINESS WIRE)--On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is the only analytical and comprehensive review of progress made toward a type 1...

November 19, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in contrast to surveyed managed care organization (MCO) pharmacy directors’...

November 19, 2012

DUSSELDORF, Germany--(BUSINESS WIRE)--The Ministry of Industry and Trade of the Russian Federation led a united Russian delegation at the world’s largest medical trade fair MEDICA 2012 and presented the OPEN RUSSIA DAY. In the forthcoming years,...

November 19, 2012

CHICAGO--(BUSINESS WIRE)--Clontech has adopted SnapGene for cloning simulation and plasmid map drawing, and has endorsed SnapGene as the ideal partner for their In-Fusion cloning kits.

November 19, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The new release is available at...

November 19, 2012

PARIS--(BUSINESS WIRE)--The 17th annual Longevity Prize of the Fondation Ipsen has been awarded to Linda Fried (Columbia University, New York, USA), in recognition of her outstanding leadership in the domain of the frailty syndrome, by an...

November 19, 2012

MADISON, Wis.--(BUSINESS WIRE)--BioForward announced today that Fritz Bittenbender, Vice President of Alliance Development and State Government Affairs for BIO

November 19, 2012

WASHINGTON--(BUSINESS WIRE)--A new 3-D “light switch” tool for could one day be used to treat conditions such as Parkinson’s and epilepsy by using gene therapy to turn individual brain cells on and off with light.

November 19, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The highest spending on Medical Science Liaisons (MSLs) occurs in the top markets, with $11.6 million spent on MSLs in the United States.

November 19, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved PROMACTA for the treatment of thrombocytopenia (low...

November 19, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Short R&D Timeline Could Lead to Larger Profits

November 19, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen Ltd. (Nasdaq: CGEN) announced today the signing of an agreement with a private U.S.-based investment company pursuant to which up to $15,000,000 in milestone related equity financing will be made...

November 19, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that top-line results of a double-blind, Phase 3 study evaluating pregabalin controlled-release (CR) formulation in patients with fibromyalgia indicate that pregabalin CR had a...

November 19, 2012

SARATOGA, Calif.--(BUSINESS WIRE)--Peer-Reviewed Study in Nature Biotechnology Identifies New Pathway for Multiple Sclerosis Treatment

November 19, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Biotechnology company AGTC, which is developing gene therapy products to treat rare retinal diseases, has raised $37.5 million from three new investors.

November 19, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics Exploring Strategic Alternatives to Maximize Growth and Shareholder Value

November 19, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq:INCY) announced today it will present at the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, November 27th at 1:30 p.m. (EST) in New York. The presentation will be webcast...

November 19, 2012

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Orgenesis Inc. (OTCBB:ORGS) (“Orgenesis” or the “Company”), a development-stage company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-...

November 19, 2012

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Coupons Make You Happier and More Relaxed, According to New Study by Claremont Graduate University

November 19, 2012

GAITHERSBURG, Md.--(BUSINESS WIRE)--OpGen Announces Expanded Adoption of Argus® Whole Genome Mapping System